Recursion Pharmaceuticals (RXRX) Q2 2025 Earnings

May 5Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.53
-0.46
-0.4
-0.33

Details

Expected EPS
-0.516
Actual EPS
-0.5
Surprise EPS
0.02
Surprise Percent
+3.1%

Description

⁨Recursion Pharmaceuticals⁩ (⁦RXRX⁩) has reported earnings of ⁦-0.5⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts